Qsemble Capital Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$249K Buy
+1,659
New +$180K 0.03% 351
2026
Q1
Sell
-5,882
Closed -$601K 505
2025
Q4
$601K Sell
5,882
-4,606
-44% -$412K 0.05% 352
2025
Q3
$655K Buy
10,488
+6,625
+171% +$360K 0.06% 295
2025
Q2
$201K Buy
+3,863
New +$173K 0.02% 407
2023
Q4
Sell
-11,505
Closed -$341K 400
2023
Q3
$341K Buy
+11,505
New +$405K 0.06% 278
2023
Q2
Sell
-9,500
Closed -$223K 259
2023
Q1
$223K Sell
9,500
-100
-1% -$2.86K 0.15% 211
2022
Q4
$261K Buy
+9,600
New +$439K 0.18% 174

Other funds holding GH

Qsemble Capital Management's GH Position: Q2 2026 in Review

Qsemble Capital Management opened a new position in Guardant Health (GH) in Q2 2026: 1,659 shares worth $249K. The stake represents 0.03% of the portfolio and ranks #351 among its holdings. This is a return to the name: Qsemble Capital Management previously reported a position in GH as recently as Q4 2025.

Qsemble Capital Management first reported a position in GH in Q4 2022 and has held it in 7 quarters since. The position peaked at $655K in Q3 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Qsemble Capital Management held 1,659 shares of Guardant Health worth $249K as of Q2 2026.
  • Guardant Health was a new Qsemble Capital Management position in Q2 2026.
  • Guardant Health made up 0.03% of Qsemble Capital Management's portfolio in Q2 2026, its #351 holding.
  • Qsemble Capital Management first reported a position in Guardant Health in Q4 2022 and has held it in 7 quarters since.
  • Qsemble Capital Management's Guardant Health position peaked at $655K in Q3 2025.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Qsemble Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.